共 50 条
- [32] Outcomes of anti-TNF versus Vedolizumab therapy for ulcerative colitis: the Leeds experience JOURNAL OF CROHNS & COLITIS, 2017, 11 : S192 - S193
- [37] Ustekinumab is effective for Patients with Ulcerative colitis ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (01): : 20 - +
- [38] Switching out of class or to another anti-TNF agent is the most effective strategy in IBD patients with immunogenicity against anti-TNF antibodies JOURNAL OF CROHNS & COLITIS, 2023, 17 : 803 - 803
- [39] Gut Microbial Species and Endotypes Associate with Remission in Ulcerative Colitis Patients Treated with Anti-TNF or Anti-integrin Therapy JOURNAL OF CROHNS & COLITIS, 2024, 18 (11): : 1819 - 1831